A few compounds come up more than any others in research inquiries we get. Here's a brief, practical overview of each — not dosing guidance, just an orientation to what's being studied and why these three specifically tend to anchor a lot of research protocols.
BPC-157
A synthetic peptide derived from a protein found in gastric juice, BPC-157 is one of the most widely studied research peptides in the tissue-repair space. Its research profile spans gastrointestinal, tendon, and general healing-related pathways, which is why it frequently shows up as a reference or comparison compound in related studies.
CJC-1295
A growth-hormone-releasing hormone (GHRH) analog, CJC-1295 is studied for its extended half-life relative to native GHRH, making it a common choice in research protocols examining sustained growth hormone pathway activity over standard short-acting analogs.
Ipamorelin
A selective growth hormone secretagogue, Ipamorelin is frequently studied alongside CJC-1295 for its comparatively selective action — research interest tends to focus on its more targeted secretagogue profile relative to older-generation compounds in the same class.
Sourcing matters more than the compound
Whichever compound your protocol calls for, the research value depends entirely on knowing exactly what's in the vial. Every peptide we carry, including all three above, ships with third-party purity and identity verification — see our guide to reading a COA for what to check.